FDA Center for Drug Evaluation and Research - What's New 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Respiratory Syncytial Virus Infection: Developing Antiviral Drugs for Prophylaxis and Treatment Guidance for Industry
Clinical Antimicrobial (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 11, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals for 2015
Novel drugs (2015): A report on the more innovative products approved by FDA. These products often help advance clinical care to another level. Each year, FDA approves hundreds of new medications, most of which are variations of previously existing products, such as important new dosage forms of alr (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals for 2016
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals for 2017
When it comes to innovation in the development of new drugs and therapeutic biological products, FDA ’s Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry at every step of the process. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals for 2018
Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA ’s Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry at every step of the process. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals for 2019
Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA ’s Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry at every step of the process. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals for 2020
The availability of new drugs and biological products often means new treatment options for patients and advances in health care for the American public (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals for 2022
Innovative drugs often mean new treatment options for patients and advances in health care for the American public. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals for 2024
Innovative drugs often mean new treatment options for patients and advances in health care for the American public. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals for 2023
Each year, CDER approves a wide range of new drugs and biological products. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Novel Drug Approvals at FDA
Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products, FDA ’s Center for Drug Evaluation and Research (CDER) supports the pharmaceutical industry at every step of the process. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Roundup: April 9, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Buying & Using Medicine Safely
The information in this section can help you work with your health professionals to make the best medicine choices, buy safely, and use medicine so it's as safe and effective as possible. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FirstCham Co., Ltd. - 672903 - 04/03/2024
CGMP/Finished Pharmaceuticals/Adulterated/Misbranded (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Antaria Pty. Ltd. - 674495 - 03/22/2024
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 9, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
